← Back to Search

Feasibility Assessment for Colonic Diseases

N/A
Waitlist Available
Led By Andrew Nettt, MD
Research Sponsored by WAE Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights

Study Summary

This trial is testing a new system for managing fluids during colonoscopies.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Colonoscope Control as assessed using a 5-point Likert scale from 1 (Strongly Disagree) to 5 (Strongly Agree).
Device Usability 1 as assessed using a 5-point Likert scale from 1 (Strongly Disagree) to 5 (Strongly Agree).
Device Usability 2 as assessed using a 5-point Likert scale from 1 (Strongly Disagree) to 5 (Strongly Agree).
+2 more
Secondary outcome measures
Number of Adverse Events
Number of Device Deficiencies
Time measured in minutes

Trial Design

1Treatment groups
Experimental Treatment
Group I: Feasibility AssessmentExperimental Treatment1 Intervention
The Poseidon System is investigational and indicated to provide a pathway to control waste fluid during irrigation of the colon. All consented patients will receive the Device use during their colonoscopy procedure.

Find a Location

Who is running the clinical trial?

WAE MedicalLead Sponsor
Andrew Nettt, MDPrincipal InvestigatorSutter Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the chief aims of this experiment?

"The primary goal of this medical study, which will be assessed over the span of 24 hours is to evaluate Human Factors. Secondary metrics that shall be investigated include Adverse Events, Device Deficiencies and Time. Specifically, safety shall encompass all adverse events from initial procedure through two-week follow up; device deficiencies address inadequacy with respect to identity, quality or performance; and time measures period between scope insertion and removal (scope-in/out)."

Answered by AI

Is enrollment for this investigation still open?

"It appears that the recruitment efforts for this trial have ceased, as per clinicaltrials.gov's records which state it was posted on September 12th 2022 and updated lastly on August 29th 2022. However, 9 other trials are currently in search of participants at present."

Answered by AI
~12 spots leftby Mar 2025